Calcium Chloride → HCID 58577654, 화합물

HRID 1429921노트

반응식

HRID 1429921 반응식
[H-].[Al+3].[Li+].[H-].[H-].[H-].[CH2:7]([N:9]1[C:17]2[C:12](=[N:13][CH:14]=[CH:15][CH:16]=2)[N:11]([C:18]2[CH:39]=[CH:38][C:21]([O:22][C:23]3[N:27]([CH2:28][C:29](OCC)=[O:30])[C:26]4[CH:34]=[CH:35][CH:36]=[CH:37][C:25]=4[N:24]=3)=[CH:20][CH:19]=2)[C:10]1=[O:40])[CH3:8].[Cl-].[Cl-].[Ca+2]>C1COCC1>[CH2:7]([N:9]1[C:17]2[C:12](=[N:13][CH:14]=[CH:15][CH:16]=2)[N:11]([C:18]2[CH:19]=[CH:20][C:21]([O:22][C:23]3[N:27]([CH2:28][CH2:29][OH:30])[C:26]4[CH:34]=[CH:35][CH:36]=[CH:37][C:25]=4[N:24]=3)=[CH:38][CH:39]=2)[C:10]1=[O:40])[CH3:8]

참가 물질

5

반응물 3

HCID 5284359Calcium ChlorideHCID 21226445Aluminium lithium hydrideHCID 58577597HCID 58577597, 화합물

생성물 1

HCID 58577654HCID 58577654, 화합물수율 55.1%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

Lithium aluminum hydride (33.2 mg) was added to a solution of ethyl {2-[4-(1-ethyl-2-oxo-1,2-dihydro-3H-imidazo[4,5-b]pyridin-3-yl)phenoxy]-1H-benzimidazol-1-yl}acetate (200 mg) in THF (4 mL) at 0° C. The mixture was stirred at room temperature under a dry atmosphere (CaCl2 tube) for 30 min. The mixture was quenched with EtOAc and concentrated in vacuo. The residue was purified by column chromatography (silica gel, eluted with 10%-50% EtOAc in hexane) to give 1-ethyl-3-(4-{[1-(2-hydroxyethyl)-1H-benzimidazol-2-yl]oxy}phenyl)-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one (100 mg) as colorless crystals.

후처리

  1. customThe mixture was quenched with EtOAc
  2. concentrationconcentrated in vacuo
  3. customThe residue was purified by column chromatography (silica gel, eluted with 10%-50% EtOAc in hexane)

출처 및 근거

ORD 기록
ord-09f0aa1526904330a809aba414e5a0d1
출처 데이터셋
uspto-grants-2015_01
특허 번호
US08940758B2

반응 노트

불러오는 중…